CClinicalTrials.gg
RecruitingNCT07424586Updated Jun 15, 2026

Improving Outcomes of Older Adults Undergoing Ostomy Surgery

An Early Phase 1 interventional study of Geriatric Assessment Strategy for Ostomy Management and Adaptation (GA-STOMA) in Ostomy - Ileostomy or Colostomy, sponsored by Massachusetts General Hospital. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-15.

Sponsored by Massachusetts General Hospital · Early Phase 1, Interventional, and Other

From the registry’s dates

  • Started Feb 2026; still recruiting 7 months later.
Phase
Early Phase 1
Study type
Interventional
Enrollment
16
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this pilot study is to learn if an intervention in patients undergoing ostomy surgery is easy to use. The overall goal of the work is to improve quality of life during recovery in the days after surgery for these patients using the intervention.

Read the detailed description

In this study the acceptability and usability of an intervention to evaluate and address biopsychosocial outcomes for older adults undergoing fecal ostomy surgery will be evaluated with the overall goal of improving patient-centered outcomes.

02

Conditions studied

  • Ostomy - Ileostomy or Colostomy

Keywords

  • ostomy
  • quality of life
  • biopsychosocial outcomes
  • web-based intervention
03

In context

Lead sponsor

Massachusetts General Hospital is the lead sponsor of 2,536 studies on the registry; 446 are open to participants now.

Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients Age 65+ years
  • clinicians age 18+ years
  • Patients undergoing fecal ostomy surgery and their clinicians

Exclusion criteria

Exclusion Criteria:

  • cognitive impairment not allowing completion of consent procedures based on the teach-back method.
05

Study design

Phase
Early Phase 1
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
16 participants (estimated)

Study arms

  • Experimental
    GA-STOMA

    A web-based intervention will be provided in addition to routine surgical care.

    Behavioral: Geriatric Assessment Strategy for Ostomy Management and Adaptation (GA-STOMA)

Interventions

  • BehavioralGeriatric Assessment Strategy for Ostomy Management and Adaptation (GA-STOMA)

    The web-based intervention provides patients with a survey and tailored content with the purpose of better supporting recovery and adaptation after surgery with a fecal ostomy

06

What researchers measure

Primary outcomes

  1. Acceptability

    Interviews will be performed to assess the ability to use the intervention, complete questions, obtain management recommendations and complete management recommendations.

    Time frame: 6 weeks

Secondary outcomes

  1. Client Satisfaction questionnaire

    This is a quantitative evaluation of intervention acceptability

    Time frame: 6 weeks after surgery date

07

Study locations

1 of 1 sites recruiting
  • MassGeneral Hospital
    Boston, Massachusetts 02114, United States
    • Christy Cauley, MD, MPH · Contact · ccauley@mgb.org · 617-726-8129
    • Christy Cauley, MD, MPH · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07424586
Lead sponsor
Massachusetts General Hospital
Collaborators
National Institute on Aging (NIA)
Responsible party
Christy E. Cauley, MD, MPH (Associate Professor of Surgery, Massachusetts General Hospital) — Principal investigator
First posted
Feb 20, 2026
Start date
Feb 11, 2026
Primary completion
Oct 1, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Jun 15, 2026

Study contacts

Christy Cauley, MD, MPH
Contact
ccauley@mgb.org
617-726-8129
Jana Zeineddine, MD
Contact
ccauley@mgb.org
617-726-8129
Christy Cauley, MD, MPH
principal investigator · MassGeneral Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion